SCHEMBL8307324

SCHEMBL8307324

Cc1ccc(COC(=O)CCOCc2ccccc2)cc1-c1n[nH]c(=O)c2cccc(C)c12

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
PARP1 P09874 8/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
ROCK1 Q13464 1/20 0.36
PIM1 P11309 1/20 0.35
CSNK1D P48730 1/20 0.35
ROCK2 O75116 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8305151 0.83 PARP1 (0.54) PARP1PIM1CSNK1D
SCHEMBL1855116 0.69 ALDH1A1 (0.61) LMNAALDH1A1SMN1; SMN2
SCHEMBL10472517 0.65 TDP1 (0.51) LMNAALDH1A1SMN1; SMN2
SCHEMBL581225 0.63 TDP1 (0.49) LMNAALDH1A1SMN1; SMN2
SCHEMBL30101115 0.62 PDE4A (0.47) KDM4ELMNAALDH1A1HPGDTNKS
SCHEMBL31014280 0.62 NPSR1 (0.62) KDM4ELMNAALDH1A1HPGDNPSR1
SCHEMBL19678716 0.62 ALDH1A1 (0.54) LMNAALDH1A1HPGDSMN1; SMN2
SCHEMBL16672928 0.62 TDP1 (0.54) LMNAALDH1A1SMN1; SMN2
SCHEMBL6181708 0.61 ALDH1A1 (0.58) LMNAALDH1A1SMN1; SMN2
SCHEMBL31110163 0.61 ALDH1A1 (0.58) LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004105700-A2 COMPOUNDS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PARP GUILDFORD PHARMACEUTICALS, INC. (US) 2004-12-09 WO disclosed